Latest Breaking News On - Head of medical regulatory affairs at medpace - Page 1 : vimarsana.com

vTv Therapeutics Announces Investment by CinRx Pharma HIGH POINT, N.C. July 25, 2022 - vTv Therapeutics Inc. today announced entry into agreements that include. | July 25, 2022

United statesCinrx pharmaJon isaacsohnMetabolic atherosclerosis research centerYale medical schoolHarvard medical schoolHead of medical regulatory affairs at medpaceTeva pharmaceuticalsTv therapeutics incChief executive officerChief medical officerExecutive vice presidentRegulatory affairsInternal medicineYale medicalAtherosclerosis research center